News
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise
Bristol Myers Squibb announced that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of the acquisition, MyoKardia shares have ceased trading on the NASDAQ Global Select...
News
Twin challenges for Indian pharma-boosting drug discovery and localising API production
India is often referred to as the ‘pharmacy of the world’; not without reason. The third largest pharmaceutical market in the world by volume, India supplies a bulk of generic drugs globally not just to under-developed countries but also...
Drug Research
Exeter University and Medicines Discovery Catapult collaborate on R&D drive
The collaboration will focus on identifying promising innovations that can be adopted through the industry in the ultimate hope of benefitting patients. The collaboration will combine the world-class research at the University of Exeter with MDC’s industry skills, discovery...
News
UK government secures 5 million doses of Moderna’s Covid-19 vaccine
The agreement follows negotiations with Moderna, who recently reported that interim data for its vaccine-candidate shows it is nearly 95% effective. The 5 millions doses would be enough for up to 2.5 million people in the UK, given that...
Drug Research
Moderna and Pfizer COVID Vaccines: The Comparison
Moderna Inc. on Monday declared that its vaccine was 94.5% effective.
This came just after a week when Pfizer & its partner BioNTech SE had gone public to state that their vaccine is more than 90% effective.
There is...
News
Virgin Atlantic Cargo launches new pharma service as it prepares for vaccine
Virgin Atlantic Cargo has added a new pharma service ahead of the launch of a new Covid-19 vaccine. The airline said its new Pharma Secure service will cater for urgent, valuable and vulnerable pharmaceutical and life sciences shipments.
The product...
News
Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read